ClinicalTrialsFinder

Carcinoma, Merkel Cell Clinical Trials in Nagoya, Aichi-ken

1 recruitingNagoya, Aichi-ken, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)

LymphomaMalignant NeoplasmCarcinoma, Merkel Cell
Merck Sharp & Dohme LLC20 enrolled3 locationsNCT07302347